← All devices 
Clinical / medical-grade · Patch / sensor · by Abbott
Abbott Lingo
An OTC glucose biosensor for metabolic coaching — FDA-cleared, syncs to Apple Health, but a recurring cost and not for insulin users.
September 2024Abbott Lingo
Mid-cycle1 yr 9 mo old
API access: No Raw data access: Yes — restricted Open source: No public repo
Clinical value
78/100
OTC FDA-cleared CGM
Empowerment
62/100
Apple Health sync; recurring cost
Everyday value
58/100
14-day sensor, single-purpose
An over-the-counter glucose biosensor built on the FreeStyle Libre platform, FDA-cleared for adults not on insulin and aimed at metabolic coaching. Accurate and syncs to Apple Health / Health Connect, but carries a recurring cost and a narrower display range.
What it measures
Continuous interstitial glucose (minute-by-minute) worn on the upper arm for up to 14 days, translated into a "Lingo Count" and habit insights.
Regulatory status
FDA-cleared — OTC iCGM (510(k)) for adults 18+ not on insulin; explicitly not for diagnosing diabetes. Distinct from the prescription FreeStyle Libre 3.
Validation & accuracy
MARD ~9.3% (FreeStyle Libre platform), with a narrower display range (~55–200 mg/dL) than the clinical Libre.
Data control & export
Raw data: restricted — auto-syncs glucose and workouts to Apple Health and Android Health Connect, which is better portability than Stelo, but there is no open developer API. API: none.
Wearability & battery
A small round adhesive arm sensor worn up to 14 days; no charging, replaced each cycle.
Cost & access
OTC. From ~$54 (2-week starter) up to ~$249 (~3 months), or ~$84/month subscription. HSA/FSA-eligible; not insurance-covered.
Who it serves
Metabolically curious adults (not on insulin) who want to build habits around glucose response.
Who is left out or burdened
Recurring cost with no insurance; not for insulin users; narrower display range.
✓ Strengths
- FDA-cleared OTC CGM — no prescription
- ~9.3% MARD on the FreeStyle Libre platform
- Syncs to Apple Health and Health Connect
- HSA/FSA-eligible; money-back on first purchase
✕ Weaknesses
- Not for insulin users; not for diagnosis
- Narrower display range than clinical Libre
- No CSV export or developer API
- Recurring ~$84/month cost, no insurance
78
Why this clinical score. A genuine OTC FDA clearance with ~9.3% MARD makes it clinically credible; held below prescription CGMs because of its non-insulin scope and narrow range.
62
Why this empowerment score. Apple Health / Health Connect sync gives it better portability than Stelo, but no CSV/API and a recurring cost keep empowerment mid-range.
58
Why this everyday score. Comfortable and forgettable, but single-purpose with recurring sensor cost.
Latest news
Reviews & coverage
Reviewers frame Lingo as a polished, beginner-friendly window into glucose trends with good coaching, but note it's a wellness relabel of Libre tech with no medical claims. Many question the value for non-diabetics given the recurring cost and tendency to over-read normal swings.
Summary is a draft synthesis of public coverage, not an endorsement. Links open a search of each outlet.
Reddit communities
Independent user communities where this device (or its category) is discussed.
Get it · manuals & support
Draft profile · public-source review, June 2026 · scores describe direction and degree, not buying advice. News, links, and prices change — verify with the manufacturer. Image is representative.